Skip to content
PIL Logo

Zoton FasTab

Last Updated on eMC 22-May-2017 View document  | Pfizer Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22-May-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 03-Apr-2017 and displayed until 22-May-2017

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 12-Jan-2017 and displayed until 03-Apr-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 11-Apr-2016 and displayed until 12-Jan-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Improved presentation of PIL

Updated on 22-Jan-2016 and displayed until 11-Apr-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Improved presentation of PIL

Updated on 09-Mar-2015 and displayed until 22-Jan-2016

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 03-Jul-2012 and displayed until 09-Mar-2015

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 10-Aug-2011 and displayed until 03-Jul-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to name of manufacturer

Updated on 24-Jun-2011 and displayed until 10-Aug-2011

Reasons for adding or updating:

  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details

Updated on 28-Apr-2011 and displayed until 24-Jun-2011

Reasons for adding or updating:

  • Change to date of revision
  • Change to dosage and administration

Updated on 14-Aug-2008 and displayed until 28-Apr-2011

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 06-Jun-2008 and displayed until 14-Aug-2008

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 25-Sep-2007 and displayed until 06-Jun-2008

Reasons for adding or updating:

  • Change to appearance of the medicine

Updated on 08-May-2007 and displayed until 25-Sep-2007

Reasons for adding or updating:

  • Change due to harmonisation of patient information leaflet

Updated on 23-Nov-2006 and displayed until 08-May-2007

Reasons for adding or updating:

  • Change of licence holder
  • Change to date of revision

Updated on 18-Sep-2002 and displayed until 23-Nov-2006

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Pfizer Limited

Company image
Address

Ramsgate Road, Sandwich, Kent, CT13 9NJ

Fax

+44 (0)1304 656 221

Telephone

+44 (0)1304 616 161

Medical Information Website

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

lansoprazole

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue